Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Non-Current Assets (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 7 years of Other Non-Current Assets readings, the most recent being $11.2 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 36.09% to $11.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $11.2 million, a 36.09% increase, with the full-year FY2025 number at $11.3 million, up 9.62% from a year prior.
  • Other Non-Current Assets hit $11.2 million in Q1 2026 for Kiniksa Pharmaceuticals International, down from $11.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $11.3 million in Q4 2025 to a low of $827000.0 in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $5.9 million (2022), compared with a mean of $6.4 million.
  • Biggest five-year swings in Other Non-Current Assets: tumbled 85.8% in 2023 and later surged 1147.28% in 2024.
  • Kiniksa Pharmaceuticals International's Other Non-Current Assets stood at $5.8 million in 2022, then tumbled by 85.8% to $827000.0 in 2023, then surged by 1147.28% to $10.3 million in 2024, then rose by 9.62% to $11.3 million in 2025, then decreased by 1.28% to $11.2 million in 2026.
  • The last three reported values for Other Non-Current Assets were $11.2 million (Q1 2026), $11.3 million (Q4 2025), and $8.3 million (Q3 2025) per Business Quant data.